Chen Linli, Liu Zhao, Wang Lu, Gu Meiyu, Luo Yongli
Department of Ultrasound, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China
Department of Cardiology, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Ann Clin Lab Sci. 2025 Jan;55(1):39-47.
During acute myocardial infarction (AMI), ferroptosis occurs in cardiomyocytes, leading to ventricular remodeling. To investigate the influence of exosomes (Exo) derived from adipose mesenchymal stem cells (AD-MSCs) on cardiomyocytes, a therapeutic approach to resolve AMI may be discovered.
The Exo of AD-MSCs was isolated and identified, and internalized into cardiomyocytes. , oxygen-sugar deprivation (OGD) was performed to cultivate H9C2 cells to simulate the AMI model, and H9C2 cells incubated with Exo. In addition, an AMI rat model was constructed, and Exo was injected into the edge of myocardial infarction. The levels of MDA, Fe, GSH, and GPX4 were detected using corresponding kit, the expression levels of ATF3, SLC7A11, PTGS2, and GPX4 were detected using western blot. The oe-ATF3 plasmid was transfected into H9C2 cells to explore the mechanism of ferroptosis regulation by Exo.
Exo was isolated and identified successfully, and further confirmed that it could be internalized into H9C2 cells. Compared with the control group, the level of apoptosis and ferroptosis in OGD group was significantly increased, while the level of cell vitality was significantly decreased. After Exo treatment, the level of ferroptosis and apoptosis was significantly decreased, while the level of cell vitality was significantly increased. However, after overexpression of ATF3 in cells, it was found that the ferroptosis level down-regulated by Exo was reversed. Further examination of the SLC7A11/Xct system showed that ATF3 could inhibit the expression of SLC7A11. In addition, compared with the AMI+PBS group, the infarct size of the AMI+Exo group was significantly reduced, and the level of cardiomyocyte apoptosis and ferroptosis was also significantly improved.
Exo derived from AD-MSCs can inhibit the expression of ATF3, promote the transport of Fe by SLC7A11/Xct system, thus inhibiting the ferroptosis of myocardial cells in AMI, increasing the activity of myocardial cells, and playing a role in alleviating AMI.
在急性心肌梗死(AMI)期间,心肌细胞会发生铁死亡,导致心室重塑。为了研究脂肪间充质干细胞(AD-MSCs)来源的外泌体(Exo)对心肌细胞的影响,可能会发现一种解决AMI的治疗方法。
分离并鉴定AD-MSCs的Exo,并使其内化到心肌细胞中。进行氧糖剥夺(OGD)培养H9C2细胞以模拟AMI模型,并将H9C2细胞与Exo共同孵育。此外,构建AMI大鼠模型,并将Exo注射到心肌梗死边缘。使用相应试剂盒检测丙二醛(MDA)、铁(Fe)、谷胱甘肽(GSH)和谷胱甘肽过氧化物酶4(GPX4)的水平,使用蛋白质印迹法检测激活转录因子3(ATF3)、溶质载体家族7成员11(SLC7A11)、前列腺素内过氧化物合酶2(PTGS2)和GPX4的表达水平。将过表达ATF3的质粒转染到H9C2细胞中,以探讨Exo调节铁死亡的机制。
成功分离并鉴定了Exo,并进一步证实其可内化到H9C2细胞中。与对照组相比,OGD组的凋亡和铁死亡水平显著升高,而细胞活力水平显著降低。Exo处理后,铁死亡和凋亡水平显著降低,而细胞活力水平显著升高。然而,在细胞中过表达ATF3后,发现Exo下调的铁死亡水平得到逆转。对SLC7A11/Xct系统的进一步检测表明,ATF3可抑制SLC7A11的表达。此外,与AMI+磷酸盐缓冲液(PBS)组相比,AMI+Exo组的梗死面积显著减小,心肌细胞凋亡和铁死亡水平也显著改善。
AD-MSCs来源的Exo可抑制ATF3的表达,促进SLC7A11/Xct系统对Fe的转运,从而抑制AMI心肌细胞的铁死亡,增加心肌细胞活性,发挥缓解AMI的作用。